🌟 What an inspiring day at the @PKDFoundation PKD Walk! 🌟 As Director of the @UCSDHealth PKD CoE, I had the immense pleasure of connecting with patients, families, and friends who came together to support PKD research. #endpkd

CKDu as a Tubulointerstitial Disease - a narrative review I wrote with Dr Magdalena Maduro : https://t.co/vFUDmQlda2 Thank You @pranavgarimella for asking us to contribute for @akdhjournal

Core Curriculum by @pranavgarimella: Autosomal Dominant Polycystic Kidney Disease: Core Curriculum 2025 https://t.co/w0YLyEZhRX (FREE)

AKDH issue on Tubulointerstitial Disease is out!

https://t.co/qMMmXe71gf Highly anticipated compendium of articles on Tubulointerstitial Diseases of the Kidney (excellent for Board Prep @RenalFellowNtwk) 🙏 for the leadership of @MPerazella ably supported by @pranavgarimella 🙏 to our contributors @nkf @akdhjournal

Presented at #ERA25: In the CONFIDENCE trial in persons with chronic kidney disease and type 2 diabetes, combination therapy with finerenone and empagliflozin led to a greater reduction in the urinary albumin-to-creatinine ratio than either drug alone. Full trial results:

Applications are now open for the Polycystic Kidney Disease Medical Directorship Program (PKD-MDP)! 🤩 This year-long program is designed for nephrologists who want to advance their expertise in the diagnosis and management of PKD and develop the leadership skills necessary to

@kidneymedmgmt @DanTheKidneyMan That hypertension is the second most common cause of CKD is a myth perpetuated by a mistaken application of the rules of causality. In fact, hypertension is largely the consequence , not the cause, of CKD

https://t.co/APQ0koxkRs

AKF is delighted to welcome @pranavgarimella as our first Chief Medical Officer! As a leader in nephrology & expert in rare kidney diseases, Dr. Garimella will enhance our capacity to serve both the patient and clinical communities. Read more: https://t.co/Jdmh3gnTmx

I am happy to announce my appointment as the first Chief Medical Officer of @KidneyFund! I look forward to lending my clinical expertise to help AKF better serve the 1 in 7 Americans living with kidney disease & joining an organization that fights kidney disease on all fronts.

Great work by @UCSDHealth for tackling several aspects of health and prevention. This care model is the future to ensuring people remains "healthy" Kudos to everyone involved.

.@ASNKidney urges Congress to replace a looming 2.83% Medicare physician payment cut with a 1.8% payment update in 2025. Read the full letter here:

Beautiful sunset over @UCSDHealth

Interactive workshops, cutting-edge plenaries, and hands-on sessions - AKI & CRRT 2025 has it all! Join us March 3-6 in sunny San Diego to elevate your critical care nephrology practice. Early bird rates end Dec 13, 2024. #AKICRRT2025 #ContinuingMedicalEducation

51% of incident PD patients in France on assisted PD! It can be done (maybe not at that scale, but we can do better for our older/dependent patients!! #kidneywk @EricWallaceuab1 @schillerb1 @nupur_nephron @eric_weinhandl

So much fun filming this CME Webinar and learning about #ADPKD risk stratification, and management from the amazing York Pei! https://t.co/IrO61Qkto2 #KidneyWk

Happening now! Moderating “Innovative AKI Strategies and Drug Discoveries’ with the awesome @SiskindLeah #Kidneywk

mandatory conference pic with nephrologist and mentor par excellence Bernard Jaar @hopkinsneph #Kidneywk

Hanging out with the amazing Scott Gilbert, winner of the @ASNKidney Robert Narins award for his constructions to educating a generations of nephrology trainees Thank yo, Scott!! #Kidneywk